Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,804.00
Bid: 1,813.00
Ask: 1,816.00
Change: 14.00 (0.78%)
Spread: 3.00 (0.165%)
Open: 1,788.00
High: 1,827.00
Low: 1,770.00
Prev. Close: 1,790.00
JMAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

JM announces sale of Diagnostic Services

3 May 2023 07:00

RNS Number : 1707Y
Johnson Matthey PLC
03 May 2023
 

 

Johnson Matthey announces the sale of Diagnostic Services to Sullivan Street Partners and Souter Investments

3rd May 2023

 

 

· Johnson Matthey announces the sale of Diagnostic Services to Sullivan Street Partners and Souter Investments for £55 million in cash

 

· Completion expected in the third quarter of 2023

 

· Execution of the divestment programme is on track to deliver targeted proceeds of at least £300 million by 31st March 2024

 

Johnson Matthey (JM) today announces the sale of Diagnostic Services, a business providing specialised detection, diagnostic, and measurement solutions. Diagnostic Services is a part of JM's Value Businesses and has been identified as non-core to JM's growth strategy.

 

Diagnostic Services will be sold to Sullivan Street Partners, a UK based Europeanmid-market private equity investor that has partnered with long term investor, Souter Investments, a Scottish based private family investment office, for £55 million. Sale proceeds are payable in cash at completion which is subject to customary completion conditions. Completion is expected in the third quarter of calendar 2023.

 

In the year ending 31st March 2022, Diagnostic Services reported external sales of £55 million, operating profit of £4 million and net assets of £35 million. A small accounting loss on sale is expected.

 

The divestment of Diagnostic Services is another transaction which progresses the delivery of one of JM's strategic milestone commitments, to complete the divestment of Value Businesses by 31st March 2024.

 

ENDS

 

Note: JM's Diagnostic Services business is also known as "Tracerco".

 

 

About Johnson Matthey

Johnson Matthey is a global leader in sustainable technologies, catalysing the net zero transition. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers' products. Our science has a global impact in areas such as low emission transport, energy, chemical processing and making the most efficient use of the planet's natural resources. Today, about 13,000 Johnson Matthey professionals collaborate with our network of customers and partners to make a real difference to the world around us. For more information visit www.matthey.com

 

About Sullivan Street Partners

Founded in 2010, Sullivan Street Partners focuses on primary lower mid-market buyouts, taking an operationally intensive and risk-pricing approach to complex situations in the UK and Ireland. The firm operates across various sectors including industrials, consumer, healthcare, business services, facilities management, and financial services. Sullivan Street plays an active role in its portfolio companies and has a strong track record of operational improvement in the businesses it backs. Sullivan Street typically takes ownership or controlling stakes in companies through investing £20m to £50m of equity. For more information visit www.sullivanstreet.co.uk

 

About Souter Investments:

Souter Investments is one of the UK's leading family investment offices specialising in private equity. Founded in 2006, Souter has invested over £500m in more than seventy unquoted companies, and currently has significant investments in over thirty-five businesses, acting either as the lead investor or as a partner for other financial sponsors.

Portfolio companies include Suir Engineering, a leading provider of innovative mechanical, electrical and instrumentation engineering solutions; Akixi, which provides cloud-based call and contact analytics solutions under a SaaS model; Amey, one of the UK's largest infrastructure services and engineering companies; LIKEZERO, a software business providing next generation data capture and contract analysis solutions to the financial services sector; and, voluntary carbon markets specialist Climate Impact Partners, which works with leading corporates, NGOs, and governments to deliver solutions for climate impact ensuring organisations meet their carbon neutral, net zero and renewable energy goals. For more information visit www.souterinvestments.com

 

 

Enquiries: 

 

Investor Relations

Martin Dunwoodie

Louise Curran

Carla Fabiano

 

Director of Investor Relations

Senior Investor Relations Manager

Senior Investor Relations Manager

 

+44 20 7269 8241

+44 20 7269 8235

+44 20 7269 8004

 

 

Media

jmpr@matthey.com

+44 207 269 8001

 

 

 

 

 

 

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774

Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISATMATMTJMBBJ
Date   Source Headline
3rd May 20243:31 pmRNSHolding(s) in Company
2nd May 20249:00 amRNSHolding(s) in Company
22nd Apr 20243:39 pmRNSHolding(s) in Company
18th Apr 20245:33 pmRNSDirector/PDMR Shareholding
17th Apr 20243:07 pmRNSHolding(s) in Company
10th Apr 20243:10 pmRNSHolding(s) in Company
10th Apr 20249:47 amRNSHolding(s) in Company
9th Apr 20249:00 amRNSHolding(s) in Company
8th Apr 20249:00 amRNSHolding(s) in Company
3rd Apr 20245:16 pmRNSHolding(s) in Company
2nd Apr 20249:01 amRNSHolding(s) in Company
2nd Apr 20249:00 amRNSHolding(s) in Company
27th Mar 20241:46 pmRNSHolding(s) in Company
22nd Mar 20243:11 pmRNSHolding(s) in Company
21st Mar 202412:13 pmRNSDirector/PDMR Shareholding
20th Mar 20247:00 amRNSJohnson Matthey sale of Medical Device Components
18th Mar 20243:05 pmRNSHolding(s) in Company
18th Mar 20242:32 pmRNSHolding(s) in Company
12th Mar 20245:12 pmRNSHolding(s) in Company
12th Mar 20249:00 amRNSHolding(s) in Company
11th Mar 20249:00 amRNSHolding(s) in Company
7th Mar 20244:20 pmRNSHolding(s) in Company
22nd Feb 20244:53 pmRNSDirector/PDMR Shareholding
20th Feb 20243:57 pmRNSHolding(s) in Company
19th Feb 20243:12 pmRNSHolding(s) in Company
15th Feb 20249:54 amRNSDirector/PDMR Shareholding
9th Feb 20244:17 pmRNSHolding(s) in Company
9th Feb 202412:31 pmRNSDirector/PDMR Shareholding
8th Feb 20242:17 pmRNSHolding(s) in Company
1st Feb 20244:08 pmRNSHolding(s) in Company
29th Jan 20243:22 pmRNSHolding(s) in Company
29th Jan 20242:37 pmRNSHolding(s) in Company
29th Jan 20242:35 pmRNSHolding(s) in Company
23rd Jan 20244:47 pmRNSHolding(s) in Company
19th Jan 20242:18 pmRNSHolding(s) in Company
18th Jan 20242:30 pmRNSHolding(s) in Company
18th Jan 202411:54 amRNSDirector/PDMR Shareholding
10th Jan 20241:29 pmRNSHolding(s) in Company
9th Jan 20241:31 pmRNSHolding(s) in Company
5th Jan 20244:50 pmRNSHolding(s) in Company
4th Jan 20244:26 pmRNSHolding(s) in Company
2nd Jan 20243:27 pmRNSHolding(s) in Company
28th Dec 20231:35 pmRNSHolding(s) in Company
21st Dec 20231:25 pmRNSDirector/PDMR Shareholding
19th Dec 20232:29 pmRNSHolding(s) in Company
15th Dec 20239:00 amRNSHolding(s) in Company
13th Dec 20233:01 pmRNSHolding(s) in Company
11th Dec 20234:20 pmRNSHolding(s) in Company
7th Dec 20231:41 pmRNSHolding(s) in Company
6th Dec 20231:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.